Main Article Content
Iga vasculitis, Henoch-Schönlein purpura, iga deposits, kidney biopsy
Henoch-Schönlein Purpura is an inflammatory disease characterized by deposits of immunoglobulin A (IgA) in the walls of blood vessels, producing a series of symptoms that mainly affect the skin, joints, gastrointestinal system and kidneys. The exact cause is not completely known, but it is believed that there is an autoimmune component as well as a genetic predisposition. It affects children more frequently than adults. Larger studies are required to evaluate the effectiveness of corticosteroids and possibly develop an approach that includes guidelines for symptomatic treatment, immunosuppression, and immunomodulation.
Methodology: This paper is based on a case report, the discussion of which will be complemented by a selection of relevant literature on the subject. This selection will be carried out through scientific search platforms such as PubMed, Springer, Elsevier and Scopus. To refine and broaden the search, bibliographic descriptors, such as DeCs/MeSH, as well as Boolean operators, such as "NOT," "OR," and "AND," in English and Spanish, will be used. Articles published in the period between 2017 and 2023 that have access to the full text will be considered.
Results: We describe the case of a 59-year-old female patient who presented with respiratory distress, abdominal pain, purpura in the lower limbs, and headache. After diagnostic testing, significant findings were identified including hematuria, proteinuria, and the presence of IgA deposits with a granular and diffuse pattern on a renal biopsy. As a result of these findings, he was diagnosed with Henoch-Schönlein purpura, with a possible infectious origin related to pneumonitis.
Discussion: The indexed bibliography on the presumed etiological factors, clinical manifestations, diagnosis and therapeutic options is analyzed.
Conclusion: The presentation of a clinical case and exhaustive literature review on IgA vasculitis is of medical interest due to its impact on health. Early detection and proper management are crucial to address effectively, preventing kidney deterioration and improving the quality of life of those affected.
2. Sara De Antonio Feu, Carabaño Aguado. Joint involvement in Schönlein-Henoch purpura: a review of a case. Rev Pediatr Aten Primary. 2017;10:71-3.
3. Borlán Fernandez. IgA vasculitis (Schönlein-Henoch purpura). Protoc Diagn Ter Pediatr. 2:225-38.
4. Piram M, Mahr A. Epidemiology of immunoglobulin A vasculitis (Henoch–Schönlein): current state of knowledge. Curr Opin Rheumatol. 2013; 25(2):171-8.
5. Leitón Solano V, Obaldía Mata A, Solano Garita S. Diagnosis and treatment of IgA vasculitis. Rev Medica Sinerg. 2022; 7(4):E791.
6. Shu M, Liu Q, Wang J, Ao R, Yang C, Fang G, et al. Measles vaccine adverse events reported in the mass vaccination campaign of Sichuan province, China from 2007 to 2008. Vaccine. 2011; 29(18):3507-10.
7. Mitsui H, Shibagaki N, Kawamura T, Matsue H, Shimada S. A clinical study of Henoch-Schönlein Purpura associated with malignancy. J Eur Acad Dermatol Venereol. 2009; 23(4):394-401.
8. Song Y, Huang X, Yu G, Qiao J, Cheng J, Wu J, et al. Pathogenesis of IgA Vasculitis: An Up-To-Date Review. Front Immunol. 2021;12:771619.
9. Yokoyama T, Sakumura N, Inoue N, Matsuda Y, Wada T. IgA Vasculitis in Japanese Patients Harboring MEFV Mutations: A Case Report and Review of the Literature. Cureus [Internet]. 2023 [cited 2023 October 3]; Available in: https://www.cureus.com/articles/131610-iga-vasculitis-in-japanese-patients-harboring-mefv-mutations-a-case-report-and-review-of-the-literature
10. Steuer AB, Cohen JM. The color of skin: purple diseases of the skin, nails, and mucosa. Clin Dermatol. 37(5):528-47.
11. Hetland L, Susrud K, Lindahl K, Bygum A. Henoch-Schönlein Purpura: A Literature Review. Acta Derm Venereol. 2017; 97(10):1160-6.
12. Sunderkötter CH, Zelger B, Chen K, Requena L, Piette W, Carlson JA, et al. Nomenclature of Cutaneous Vasculitis: Dermatologic Addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheumatol. 2018; 70(2):171-84.
13. Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis. 2010; 69(5):798-806.
14. Roman C, Dima B, Muyshont L, Schurmans T, Gilliaux O. Indications and efficiency of dapsone in IgA vasculitis (Henoch-Schonlein purpura): case series and a review of the literature. Eur J Pediatr. 2019; 178(8):1275-81.
15. Maritati F, Fenoglio R, Pillebout E, Emmi G, Urban ML, Rocco R, et al. Brief Report: Rituximab for the Treatment of Adult‐Onset IgA Vasculitis (Henoch‐Schönlein). Arthritis Rheumatol. 2018; 70(1):109-14.